CurrentSAMHSA-TIPSPolicy N/A

OTP holiday unsupervised dose exception guidance

Guidance for Opioid Treatment Programs (OTPs) on submitting requests for exceptions to allow unsupervised take-home doses around specified federal holidays and related weekend closures; applies to OTP medical directors and state authorities.

Policy Summary

PayerSAMHSA-TIPS

PolicyOTP holiday unsupervised dose exception guidance

Policy CodePolicy N/A

Change TypeNo material change

Effective DateN/A

Next Review DateN/A

Key ActionSubmit program-wide holiday closure exception requests via the OTP extranet and include arrangements for patients and total patient count in the comments.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

up to 28 daysmax for stable patients

up to 14 daysmax for less stable patients

3holiday periods noted

Coverage Criteria for OTP Holiday Unsupervised Dose Exceptions

Holiday closure exception

Covered when ALL of the following are met

Holiday exception request requirements: Program-wide requests submitted via the OTP extranet include arrangements for patients not receiving unsupervised doses and the total number of patients for whom the exception is sought

State Opioid Treatment Authority (SOTA) approval and compliance with federal regulations required

Blanket exception (historical/emergency)

March 16, 2020 blanket exception: States requesting the blanket exception could allow up to 28 days of unsupervised doses for stable patients and up to 14 days for less stable patients deemed able to handle them28 days / 14 days

Applies only where state requested the exception

Policy Summary

PayerSAMHSA-TIPS

PolicyOTP holiday unsupervised dose exception guidance

Policy CodePolicy N/A

Change TypeNo material change

Effective DateN/A

Next Review DateN/A

Key ActionSubmit program-wide holiday closure exception requests via the OTP extranet and include arrangements for patients and total patient count in the comments.

SourceLink

On This Page

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Provider Submission and Documentation Requirements

Prior Authorization

Holiday exception submission

Program-wide holiday-closure exception requests must be submitted via the Opioid Treatment Program (OTP) extranet. In the form's comments section, specify the arrangements for patients who will not receive unsupervised (take-home) doses and provide the total number of patients included in the request. OTP medical directors must ensure alternative arrangements for medication continuity for patients whose safety or therapeutic needs make unsupervised doses inappropriate.

Submit via OTP extranet
Include arrangements for patients not receiving unsupervised doses
Provide total number of patients covered by the request

Documentation Required

PROVIDER ACTIONS

OTP medical directors and providers must take the following actions when seeking program-wide holiday exceptions: use the OTP extranet submission pathway, include a clear plan for continuity of medication for patients who will not receive unsupervised doses, and confirm the count of affected patients. Ensure alternative arrangements are documented for any patient where the therapeutic benefit of unsupervised dosing does not outweigh safety risks.

Use OTP extranet for program-wide requests
Document continuity plans for affected patients
Document safety-based exclusions from unsupervised dosing

Documentation Required

Submission and documentation requirements

When submitting a program-wide exception request, include the following in the comments section of the OTP extranet form: a description of the arrangements for patients who will not receive unsupervised doses (e.g., dosing schedules, emergency contact/coverage plans, pick-up alternatives), and the total number of patients for whom the exception is requested. Retain documentation of the OTP medical director's clinical rationale when alternative arrangements are made because unsupervised dosing is not clinically appropriate for specific patients.

Describe alternate arrangements for medication continuity
Provide the total number of patients included in the request
Retain clinical rationale and documentation for patients excluded from unsupervised dosing

Denial Risk

Denial trigger for lack of state exception

If the state did not request the March 16, 2020 blanket exception allowing up to 28 days (stable) or 14 days (less stable) of unsupervised doses, OTPs must follow federal regulatory criteria for unsupervised doses and submit individual or program-wide exception requests for clinic closure dates. Requests or claims for unsupervised dosing without an approved state/federal exception and without meeting federal regulatory criteria may be denied.

States that did not request the March 16, 2020 blanket exception: follow federal criteria and submit exceptions as needed
Risk of denial if state did not request blanket exception and federal criteria are not met

Note

State blanket exception reminder

Reminder: SAMHSA's March 16, 2020 guidance allowed states to request a blanket exception for all stable patients to receive up to 28 days of unsupervised doses and up to 14 days for less-stable patients deemed safe by the OTP medical director. Verify whether your state requested this blanket exception before submitting program-wide requests; if it did, follow state-level approval instructions. If not, submit the required OTP extranet request with the documentation described above.

Blanket exception (if requested by state): up to 28 days for stable patients, up to 14 days for less-stable patients
If state did not request blanket exception: submit OTP extranet request and meet federal criteria

Background and Rationale

Unsupervised (take‑home) dosing in Opioid Treatment Programs requires balancing the therapeutic benefit to individual patients against potential safety risks. OTP medical directors are responsible for assessing each patient and ensuring that, when the therapeutic benefits of take‑home doses do not outweigh safety risks, appropriate alternative arrangements for medication continuity are implemented.

SAMHSA previously issued guidance (March 16, 2020) allowing states that requested a blanket exception to permit up to 28 days of unsupervised doses for stable patients and up to 14 days for less stable patients judged able to handle them. For holiday or closure‑related exception requests, OTPs must submit program‑wide requests through the OTP extranet and document the alternative plans and patient counts in the comments section; state approval by the State Opioid Treatment Authority (SOTA) and compliance with federal regulations remain applicable.

OpenPayer

OTP holiday unsupervised dose exception guidance

Coverage Criteria for OTP Holiday Unsupervised Dose Exceptions

Provider Submission and Documentation Requirements

Background and Rationale

Key Definitions and Historical Exceptions

Medication for Opioid Use Disorder (Take-home Doses)